FTC Settles With Supplement Marketer In Prison From FDA Investigation
This article was originally published in The Rose Sheet
Executive Summary
FTC has settlement with CellMark and CEO Derek Vest alleging advertising regulation violations in marketing CellAssure supplements to treat cancer-related malnutrition, at $248 for a month's supply, and Cognify for treatment-related cognitive dysfunction sold for $79.